Royal Bank of Canada’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Sell |
90
-789
| -90% | -$1.68K | ﹤0.01% | 7462 |
|
|
2025
Q4 | $1K | Buy |
879
+404
| +85% | +$635 | ﹤0.01% | 7016 |
|
|
2025
Q3 | $1K | Buy |
475
+398
| +517% | +$644 | ﹤0.01% | 7003 |
|
|
2025
Q2 | $0 | Sell |
77
-4
| -5% | -$6 | ﹤0.01% | 7218 |
|
|
2025
Q1 | $0 | Sell |
81
-2,376
| -97% | -$6.21K | ﹤0.01% | 7080 |
|
|
2024
Q4 | $8K | Sell |
2,457
-3,584
| -59% | -$12.9K | ﹤0.01% | 6407 |
|
|
2024
Q3 | $20K | Buy |
6,041
+9
| +0.1% | +$35 | ﹤0.01% | 6107 |
|
|
2024
Q2 | $26K | Sell |
6,032
-5,831
| -49% | -$56.8K | ﹤0.01% | 5950 |
|
|
2024
Q1 | $175K | Sell |
11,863
-16,974
| -59% | -$257K | ﹤0.01% | 4806 |
|
|
2023
Q4 | $278K | Buy |
28,837
+8,876
| +44% | +$61.4K | ﹤0.01% | 4802 |
|
|
2023
Q3 | $93K | Buy |
19,961
+14,039
| +237% | +$69.9K | ﹤0.01% | 5427 |
|
|
2023
Q2 | $32K | Buy |
5,922
+2,153
| +57% | +$13.3K | ﹤0.01% | 5977 |
|
|
2023
Q1 | $27K | Sell |
3,769
-5,697
| -60% | -$34.3K | ﹤0.01% | 5914 |
|
|
2022
Q4 | $63K | Buy |
9,466
+8,312
| +720% | +$45.6K | ﹤0.01% | 5757 |
|
|
2022
Q3 | $4K | Buy |
1,154
+815
| +240% | +$3.12K | ﹤0.01% | 6816 |
|
|
2022
Q2 | $1K | Sell |
339
-5,950
| -95% | -$31.3K | ﹤0.01% | 7154 |
|
|
2022
Q1 | $56K | Sell |
6,289
-8,387
| -57% | -$92.6K | ﹤0.01% | 6008 |
|
|
2021
Q4 | $236K | Buy |
14,676
+7,047
| +92% | +$133K | ﹤0.01% | 5174 |
|
|
2021
Q3 | $159K | Buy |
7,629
+990
| +15% | +$23.8K | ﹤0.01% | 5369 |
|
|
2021
Q2 | $178K | Buy |
6,639
+676
| +11% | +$19.8K | ﹤0.01% | 5170 |
|
|
2021
Q1 | $190K | Buy |
5,963
+4,543
| +320% | +$110K | ﹤0.01% | 4992 |
|
|
2020
Q4 | $32K | Sell |
1,420
-105
| -7% | -$2.42K | ﹤0.01% | 5848 |
|
|
2020
Q3 | $38K | Sell |
1,525
-546
| -26% | -$14.9K | ﹤0.01% | 5464 |
|
|
2020
Q2 | $58K | Sell |
2,071
-38
| -2% | -$660 | ﹤0.01% | 5160 |
|
|
2020
Q1 | $12K | Sell |
2,109
-383
| -15% | -$3.48K | ﹤0.01% | 5766 |
|
|
2019
Q4 | $28K | Buy |
2,492
+1,984
| +391% | +$19.6K | ﹤0.01% | 5711 |
|
|
2019
Q3 | $6K | Buy |
508
+10
| +2% | +$144 | ﹤0.01% | 5960 |
|
|
2019
Q2 | $8K | Sell |
498
-50
| -9% | -$859 | ﹤0.01% | 6108 |
|
|
2019
Q1 | $10K | Sell |
548
-307
| -36% | -$5.31K | ﹤0.01% | 5980 |
|
|
2018
Q4 | $11K | Sell |
855
-1,085
| -56% | -$18.2K | ﹤0.01% | 5844 |
|
|
2018
Q3 | $41K | Buy |
1,940
+327
| +20% | +$6.97K | ﹤0.01% | 5330 |
|
|
2018
Q2 | $33K | Buy |
1,613
+127
| +9% | +$2.86K | ﹤0.01% | 5329 |
|
|
2018
Q1 | $37K | Sell |
1,486
-1,725
| -54% | -$41.9K | ﹤0.01% | 5187 |
|
|
2017
Q4 | $61K | Sell |
3,211
-636
| -17% | -$11.9K | ﹤0.01% | 5078 |
|
|
2017
Q3 | $71K | Buy |
3,847
+2,963
| +335% | +$51.3K | ﹤0.01% | 5230 |
|
|
2017
Q2 | $15K | Sell |
884
-681
| -44% | -$13K | ﹤0.01% | 5657 |
|
|
2017
Q1 | $29K | Sell |
1,565
-146
| -9% | -$2.82K | ﹤0.01% | 5429 |
|
|
2016
Q4 | $35K | Sell |
1,711
-24,919
| -94% | -$627K | ﹤0.01% | 5461 |
|
|
2016
Q3 | $797K | Buy |
26,630
+12,200
| +85% | +$363K | ﹤0.01% | 3301 |
|
|
2016
Q2 | $390K | Buy |
14,430
+13,250
| +1,123% | +$299K | ﹤0.01% | 3901 |
|
|
2016
Q1 | $23K | Sell |
1,180
-12,914
| -92% | -$246K | ﹤0.01% | 5435 |
|
|
2015
Q4 | $436K | Buy |
14,094
+11,678
| +483% | +$355K | ﹤0.01% | 3908 |
|
|
2015
Q3 | $52K | Sell |
2,416
-4,086
| -63% | -$128K | ﹤0.01% | 5111 |
|
|
2015
Q2 | $246K | Sell |
6,502
-203
| -3% | -$6.67K | ﹤0.01% | 4204 |
|
|
2015
Q1 | $210K | Sell |
6,705
-7,082
| -51% | -$240K | ﹤0.01% | 4202 |
|
|
2014
Q4 | $483K | Buy |
13,787
+4,226
| +44% | +$105K | ﹤0.01% | 3594 |
|
|
2014
Q3 | $199K | Buy |
9,561
+7,411
| +345% | +$153K | ﹤0.01% | 4190 |
|
|
2014
Q2 | $47K | Buy |
2,150
+1,050
| +95% | +$22.1K | ﹤0.01% | 4878 |
|
|
2014
Q1 | $31K | Sell |
1,100
-1,400
| -56% | -$49.4K | ﹤0.01% | 5045 |
|
|
2013
Q4 | $69K | Buy |
+2,500
| New | +$65.4K | ﹤0.01% | 4765 |
|
Other funds holding MGNX
AC
VCM
RCM
WA
Royal Bank of Canada's MGNX Position: Q1 2026 in Review
Royal Bank of Canada reduced its MacroGenics (MGNX) stake by 90% in Q1 2026, selling an estimated $1.68K and leaving 90 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7462.
Royal Bank of Canada first reported a position in MGNX in Q4 2013 and has held it in 50 quarters since. The position peaked at $797K in Q3 2016. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.
- Royal Bank of Canada held 90 shares of MacroGenics worth $0 as of Q1 2026.
- Royal Bank of Canada sold 789 MacroGenics shares in Q1 2026, an estimated $1.68K.
- MacroGenics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7462 holding.
- Royal Bank of Canada first reported a position in MacroGenics in Q4 2013 and has held it in 50 quarters since.
- Royal Bank of Canada's MacroGenics position peaked at $797K in Q3 2016.
- 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.